Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Environmental Science and Pollution Research International|March 11, 2023
Toxicity evaluation of iron oxide nanoparticles to freshwater cyanobacteria Nostoc ellipsosporumMukesh Kumar, Kunal Seth, Sunita Choudhary, et al.Biomedical Materials (Bristol, England)|September 12, 2025
Shortwave infrared imaging-guided radiosensitization using rare-earth-doped nanoparticles delivered via microneedles for enhanced melanoma therapyMohd Yaqub Khan, Jen-Kun Chen, Lokesh Agrawal, et al.Methods in Enzymology|October 11, 2022
In vitro and in cellulae methods for determining the target protein SUMOylationSajeev T K, Aswini Kumar Panda, Jyotsna Kawadkar, et al.Plos Pathogens|June 26, 2025
Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axisRiya Ghosh, Garima Joshi, Nishith M Shrimali, et al.Annals of Indian Academy of Neurology|July 5, 2021
Enhancing Quality of Life in Indian Parkinson's Disease Patients with Improved Measurement of Psychological Domains: A PerspectiveAshima Nehra, Priya Sharma, Avneesh Narain, et al.Life Science Alliance|April 2, 2025
Plasmacytoid dendritic cell sensing of hepatitis E virus is shaped by both viral and host factorsGarima Joshi, Elodie Décembre, Jacques Brocard, et al.Journal of Thrombosis and Haemostasis : JTH|November 29, 2023
Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infectionsAnamika Singh, Riya Ghosh, Tejeswara Rao Asuru, et al.Journal of Neuro-Oncology|April 11, 2018
A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcomeNarayan Adhikari, Ahitagni Biswas, Ajay Gogia, et al.Nature Communications|February 8, 2023
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2Manon Venet, Margarida Sa Ribeiro, Elodie Décembre, et al.Iscience|October 1, 2025
Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.Pageof 4